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Studies have shown that exposure to chronic mild stress decreases ethanol intake and
preference in dopamine D2 receptor wild-type mice (Drd2+/+), while it increases intake in
heterozygous (Drd2+/−) and knockout (Drd2−/−) mice. Dopaminergic neurotransmission
in the basal forebrain plays a major role in the reinforcing actions of ethanol as well as
in brain responses to stress. In order to identify neurochemical changes associated with
the regulation of ethanol intake, we used in vitro receptor autoradiography to measure
the levels and distribution of dopamine D1 and D2 receptors and dopamine transporters
(DAT). Receptor levels were measured in the basal forebrain of Drd2+/+, Drd2+/−, and
Drd2−/− mice belonging to one of four groups: control (C), ethanol intake (E), chronic
mild stress exposure (S), and ethanol intake under chronic mild stress (ES). D2 receptor
levels were higher in the lateral and medial striatum of Drd2+/+ ES mice, compared
with Drd2+/+ E mice. Ethanol intake in Drd2+/+ mice was negatively correlated with
striatal D2 receptor levels. D2 receptor levels in Drd2+/− mice were the same among
the four treatment groups. DAT levels were lower in Drd2+/− C and Drd2−/− C mice,
compared with Drd2+/+ C mice. Among Drd2+/− mice, S and ES groups had higher
DAT levels compared with C and E groups in most regions examined. In Drd2−/− mice,
ethanol intake was positively correlated with DAT levels in all regions studied. D1 receptor
levels were lower in Drd2+/− and Drd2−/− mice, compared with Drd2+/+, in all regions
examined and remained unaffected by all treatments. The results suggest that in normal
mice, ethanol intake is associated with D2 receptor-mediated neurotransmission, which
exerts a protective effect against ethanol overconsumption under stress. In mice with
low Drd2 expression, where DRD2 levels are not further modulated, ethanol intake
is associated with DAT function which is upregulated under stress leading to ethanol
overconsumption.
Keywords: dopamine transporter, D2 receptor, D1 receptor, chronic mild stress, ethanol
Introduction
Research shows that alcohol addiction has a strong genetic component shaped by many genes
(for review see Enoch, 2014). Drd2 encodes for the dopamine D2 receptor protein and is one
of these genes with a strong regulatory role on alcohol intake. In vivo, in vitro, preclinical, and
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animal studies have shown that alcoholism and ethanol
(ETOH) consumption are negatively modulated by dopamine
D2 receptors (Blum et al., 1990; Stefanini et al., 1992; McBride
et al., 1993; Volkow et al., 1996, 2006; Thanos et al., 2001, 2005;
Tupala et al., 2001). Due to the comorbid nature of the disease,
alcohol-related studies often investigate the role of stress in the
development of alcoholism either through direct, and reciprocal,
interactions between stress experience and levels of alcohol intake
(Anthenelli and Grandison, 2012) or through more complex
interactions among stress, ETOH consumption, and specific
genetic factors (Anthenelli, 2012).
We have previously shown that when normal, Drd2+/+,
mice are exposed to chronic mild stress (CMS) they decrease
their ETOH intake and preference. In contrast, Drd2+/− and
Drd2−/− mice exposed to the same CMS protocol increase their
ETOH intake and preference (Delis et al., 2013). Here we sought
to study responses of the brain dopamine system relating to
CMS and ETOH intake, as a function of Drd2 expression. To
this purpose, we studied dopamine D1 and D2 receptor and
dopamine transporter (DAT) levels in the basal forebrain of
Drd2+/+, Drd2+/−, and Drd2−/− mice that were exposed to
CMS, ETOH, or their combination. Our study showed that lower
ETOH intake under CMS in Drd2+/+ mice was associated with
increased D2 receptor levels in the striatum, in agreement with
previous findings. In contrast, higher ETOH intake under CMS
in Drd2+/− and Drd2−/− mice was associated with higher DAT
levels in the striatum and the n. accumbens.
Materials and Methods
Animals
Eighty-six male Drd2+/+, Drd2+/−, and Drd2−/− mice were
used in this study. The mice were originally obtained from
the laboratory of Dr. David Grandy and bred accordingly as
previously described (Kelly et al., 1998) from Drd2+/− breeders
congenic on C57Bl6 strain. After weaning, themice were tattooed
on the tail and a 1mm long tailsnip was also obtained and used
for genotyping (Transnetyx, Cordova, TN). All animals were
individually housed and kept on a 12:12 L/D reverse cycle with
lights off at 07:00. Food and water were provided ad lib. The
Institutional Animal Care and Use Committee (IACUC) of Stony
Brook University approved this work in accordance with the
guidelines established by the National Institutes of Health in “The
Guide for Care and Use of Laboratory Animals.”
Chronic Mild Stress and Ethanol Treatments
The animals were randomly assigned to one of the four following
groups: control, chronic mild stress (CMS) only, ETOH only,
CMS+ ETOH, as described in detail in our previous publication
(Delis et al., 2013). The CMS protocol was adapted from previous
studies (Muscat et al., 1992) but did not include food and water
deprivation. All mice had access to two bottles of water starting
1 week prior to the beginning of the behavioral experiments.
Mice in the two groups that were given ETOH (E and ES) had
continuous access to both 5% (v/v) ETOH and water starting
from the beginning of Week 2. Mice not in an ETOH group
continued to have access to two bottles of water throughout the
study. The position of the bottles was switched daily to prevent a
position preference bias.
In Vitro Receptor Autoradiography
Twenty four hours after the end of the experiment, between
09:00 and 12:00, mice were anesthetized with isoflurane and
decapitated; brains were rapidly extracted, flash-frozen in methyl
butane, and stored at −80◦C. Fifteen micrometer-thick coronal
brain sections were cut with the use of a cryostat, thaw-
mounted on glass slides, and stored at −20◦C in tightly
sealed slide boxes until the day of the receptor binding
experiment.
Dopamine Transporter (DAT) binding was assayed according
to a previously established protocol (Hebert et al., 1999)
using 3.5 nM [3H]WIN35428 (Specific activity 64Ci/mmol,
PerkinElmer, Waltham, MA) as the radioligand. Non-specific
binding was determined in the presence of 30µM cocaine
(Sigma-Aldrich, USA). The total sample size was 86, with 6–9
mice per group.
D1 dopamine receptor binding was performed according to a
previously established protocol (Tarazi et al., 1997) using 2.5 nM
[3H]SCH 23390 (Specific activity 85Ci/mmol, PerkinElmer,
Waltham, MA) and 40 nM ketanserin to block 5HT2a binding
sites. Non-specific binding was determined in the presence of
1µM cis-flupenthixol (Sigma Aldrich, USA). The total sample
size was 81, with 6–8 mice per group. Slides or sections from 5
mice were damaged during the assay and were not analyzed.
D2 dopamine receptor binding was performed according
to a previously established protocol (Tarazi et al., 1997) using
2 nM [3H]raclopride (70Ci/mmol, PerkinElmer, Waltham, MA).
Non-specific binding was determined in the presence of 10µM
sulpiride (Sigma Aldrich, USA). Binding was performed on tissue
from Drd2+/+ and Drd2+/− mice and the total sample size was
60, with 6–7 mice per group.
Quantification
The slides were exposed to 3H-sensitive film (BiomaxMR,
Kodak, USA) for 4–12 weeks along with [3H] microscales
(ARC, St. Louis, MO, USA). The films were developed in
Kodak D19 developer and scanned under constant conditions.
Optical densities and bound radioactivity were measured
with Image J software. The main body of the striatum was
divided in quadrants [dorsolateral (DL), dorsomedial (DM),
ventrolateral (VL), ventromedial (VM)], and the caudal striatal
sections (the tail of the striatum) in two parts (dorsal,
ventral).
Statistical Analysis
Receptor autoradiography measurements were analyzed using a
three-way ANOVA, with Genotype (3 levels for DAT and D1
binding; 2 levels for D2 binding), Ethanol (2 levels, H2O/ETOH)
and Stress (2 levels, NO/CMS) as between-subjects factors. When
appropriate, the Tukey post-hoc test was applied to determine the
significant pairwise differences. Overall threshold of significance
was set at p < 0.05. All data are presented as mean ± standard
error of the mean.
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Results
Ethanol Intake
We previously showed that CMS decreased ETOH intake and
preference in Drd2+/+ mice and increased it in Drd2+/− and
Drd2−/− mice (Delis et al., 2013). These results are presented
in Table 1 to help the reader follow the results and discussion
of the current study. CMS-induced decrease in Drd2+/+ ETOH
intake/preference was driven by their lower ETOH consumption,
while the respective increases in Drd2+/− and Drd2−/− were
driven by their higher ETOH consumption as well as their
lower water intake (Table 1) (Two-way ANOVA for water
intake, with Genotype and Stress as between subjects factors:
Genotype × Stress F(2, 74) = 3.22, p = 0.041, Drd2
+/+:
No Stress vs. CMS p = 0.99, Drd2+/−: No Stress vs. CMS
p = 0.011, Drd2−/−: No Stress vs. CMS p = 0.041).
Body weights and total liquid intake were not affected by the
treatments.
DAT Binding
We performed an in vitro quantitative autoradiographic study
of [3H]WIN35428 specific binding to determine changes in the
levels and distribution of dopamine transporters associated with
TABLE 1 | Ethanol intake and preference modulated by chronic mild stress
and Drd2 expression.
Drd2+/+ Drd2+/− Drd2−/−
Average % E 52.9 ± 2.5 41.6 ± 2.9∧ 32.9 ± 2.4 ∧
preference SE 45.7 ± 1.2* 55.6 ± 2.3*∧ 47.1 ± 3.6*
Total ETOH intake E 95.2 ± 4.5 65.6 ± 5.7∧ 53.6 ± 6.7∧
(g ETOH/kg b.w.) SE 63.8 ± 4.5* 86.2 ± 7.8*∧ 77.2 ± 6.9*
Total ETOH solution
intake
E 2408 ± 143 1663 ± 144∧ 1359 ± 168∧
(g solution/kg b.w.) SE 1618 ± 114* 2185 ± 224*∧ 1960 ± 175*
Total H2O intake E 2110 ± 210 2533 ± 182 2797 ± 302
from H2O bottle
(g H2O/kg b.w.) SE 2108 ± 106 1600 ± 127* 1983 ± 259*
C 4330 ± 277 3773 ± 119 4073 ± 241
Total liquid intake E 4518 ± 276 4196 ± 297 4156 ± 452
(g/kg b.w.) S 4261 ± 241 3800 ± 193 4220 ± 206
SE 3726 ± 153 3785 ± 300 3943 ± 337
Body weight (g)
C 27.4 ± 0.7 27.2 ± 0.4 28.1 ± 0.6
E 28.7 ± 1.0 27.0 ± 0.3 27.9 ± 0.5
S 28.9 ± 0.5 28.2 ± 0.7 27.6 ± 0.6
SE 28.3 ± 1.0 28.0 ± 0.5 28.6 ± 0.6
C, control; E, ETOH 2 bottle choice without CMS; S, CMS exposure; SE, ETOH 2
bottle choice with CMS; Average % preference was calculated as average daily [ETOH
solution consumed (g)/total liquid consumption (g)]; “Total H2O intake from H2O bottle”
corresponds to intake during weeks 2–4, in order to be compared to “ETOH solution
intake” during the same period. “Total liquid intake” corresponds to liquid intake from the
2 bottles during weeks 2–4. “Body weight” corresponds to average body weight during
weeks 2–4. b.w.: body weight. *Compared with E, ∧ compared with Drd2+/+.
Drd2 expression, with CMS exposure, and with ETOH intake
(Figure 1). Three-way ANOVA for [3H]WIN35428 specific
binding showed significant main effects of Genotype and Stress
and a significant Genotype × Stress interaction in most regions
studied. Post-hoc pairwise comparisons with Tukey test showed
that non-stressed (C and E) Drd2+/+ mice had significantly
higher DAT binding levels compared with non-stressedDrd2+/−
and non-stressed Drd2−/− mice in the four quadrants of the
striatum. The results also showed that stressed Drd2+/− mice
(S and SE) had significantly higher DAT binding compared with
non-stressed mice (C and E) of the same genotype in the four
quadrants and the tail of the striatum and in the n. accumbens
(DL striatum: Genotype F(2, 74) = 20.99, p < 0.001, Stress
F(1, 74) = 17.86, p < 0.001, Genotype × Stress F(2, 74) = 3.08,
p = 0.041; No Stress: Drd2+/+ vs. Drd2+/−p = 0.012, Drd2+/+
vs. Drd2−/−p = 0.002; CMS: Drd2+/+ vs. Drd2−/−p < 0.001,
Drd2+/− vs. Drd2−/−p = 0.001; Drd2+/−: CMS vs. No Stress:
p < 0.001. VL striatum: Genotype F(2, 74) = 21.76, p < 0.001,
Stress F(1, 74) = 15.59, p < 0.001, Genotype × Stress F(2, 74) =
3.22, p = 0.045; No Stress: Drd2+/+ vs. Drd2+/−p = 0.016,
Drd2+/+ vs.Drd2−/−p = 0.001;CMS:Drd2+/+ vs.Drd2−/−p <
0.001, Drd2+/− vs. Drd2−/−p = 0.003; Drd2+/−: CMS vs. No
Stress: p = 0.002. DM striatum: Genotype F(2, 74) = 14.14,
p < 0.001, Stress F(1, 74) = 12.36, p < 0.001, Genotype
× Stress F(2, 74) = 4.87, p = 0.010; No Stress: Drd2
+/+ vs.
Drd2+/−p = 0.007, Drd2+/+ vs. Drd2−/−p = 0.013; CMS:
Drd2+/+ vs. Drd2−/−p = 0.006, Drd2+/− vs. Drd2−/−p =
0.003; Drd2+/−: CMS vs. No Stress: p < 0.001. VM striatum:
Genotype F(2, 74) = 19.45, p < 0.001, Stress F(1, 74) = 15.21, p <
0.001, Genotype × Stress F(2, 74) = 4.01, p = 0.022; No Stress:
Drd2+/+ vs. Drd2+/−p = 0.005, Drd2+/+ vs. Drd2−/−p =
0.002; CMS: Drd2+/+ vs. Drd2−/−p < 0.001, Drd2+/− vs.
Drd2−/−p = 0.002; Drd2+/−: CMS vs. No Stress: p < 0.001.
Nucleus Accumbens: Genotype F(2, 74) = 5.54, p = 0.005, Stress
F(1, 74) = 14.17, p < 0.001, Genotype × Stress F(2, 74) = 4.49,
p = 0.014; CMS: Drd2+/− vs. Drd2−/−p = 0.04; Drd2+/−:
CMS vs. No Stress: p < 0.001. Olfactory tubercle: Genotype
F(2, 74) = 6.74, p = 0.002, Stress F(1, 74) = 9.46, p = 0.003. D
tail: Genotype F(2, 74) = 10.45, p < 0.001, Stress F(1, 74) = 15.22,
p < 0.001, Genotype × Stress F(2, 74) = 3.47, p = 0.036;
CMS:Drd2+/+ vs.Drd2−/−p = 0.023,Drd2+/− vs.Drd2−/−p =
0.001; Drd2+/−: CMS vs. No Stress: p < 0.001. V tail: Genotype
F(2, 74) = 17.99, p < 0.001, Stress F(1, 74) = 19.04, p < 0.001,
Genotype× Stress F(2, 74) = 4.47, p = 0.036; CMS: Drd2
+/+ vs.
Drd2−/−p = 0.006, Drd2+/− vs. Drd2−/−p < 0.001; Drd2+/−:
CMS vs. No Stress: p = 0.001.).
D2 Receptor Binding
We also studied changes in the basal forebrain D2 receptor levels,
as determined with [3H]raclopride specific binding, associated
with Drd2 expression, with CMS exposure, and with ETOH
intake (Figure 2). Three-way ANOVA for [3H]raclopride specific
binding showed a significant main effect of Genotype in all
regions studied and a Genotype × Stress × Ethanol interaction
in the DL, VL, and DM quadrants of the striatum. Tukey post-
hoc tests showed that Drd2+/+ mice had significantly higher D2
dopamine receptor levels compared with Drd2+/− mice in all
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FIGURE 1 | Specific [3H]WIN35428 binding in the basal forebrain of
Drd2+/+, Drd2+/−,andDrd2−/−mice. The bars represent mean + S.E.M.,
C, control; E, ethanol; S, chronic mild stress (CMS); SE CMS + ETOH;
∗compared with C and E; Drd2−/− and non-stressed Drd2+/− measures are
significantly different from the respective Drd2+/+ measures (for details please
see Results).
regions studied. The results also showed that Drd2+/+ ES mice
had significantly higher D2 receptor levels than Drd2+/+ E mice
in the DL, VL, and DM quadrants of the striatum (DL striatum:
Genotype F(1, 52) = 342.71, p < 0.001, Genotype × Stress ×
Ethanol F(1, 52) = 4.34, p = 0.042; Genotype: Drd2
+/+ C vs.
Drd2+/− C p < 0.001, Drd2+/+E vs. Drd2+/− E p < 0.001,
Drd2+/+S vs. Drd2+/− S p < 0.001, Drd2+/+ES vs. Drd2+/− ES
p < 0.001; Drd2+/+: E vs. ES p < 0.001. VL striatum: Genotype
F(1, 52) = 360.73, p < 0.001, Genotype × Stress × Ethanol
F(1, 52) = 4.30, p = 0.043; Genotype: Drd2
+/+ C vs. Drd2+/−
C p < 0.001, Drd2+/+E vs. Drd2+/− E p < 0.001, Drd2+/+S vs.
Drd2+/− S p < 0.001, Drd2+/+ES vs. Drd2+/− ES p < 0.001;
Drd2
+/+: E vs. ES p = 0.002. DM striatum: Genotype F(1, 52) =
485.75, p < 0.001, Genotype × Stress × Ethanol F(1, 52) =
4.03, p = 0.047; Genotype: Drd2+/+ vs. Drd2+/− p < 0.001,
Drd2+/+E vs. Drd2+/− E p < 0.001, Drd2+/+S vs. Drd2+/− S
p < 0.001, Drd2+/+ES vs. Drd2+/− ES p < 0.001; Drd2+/+: E
vs. ES p = 0.001. VM striatum: Genotype F(1, 52) = 467.42,
p < 0.001;Drd2+/+ vs.Drd2+/− p < 0.001.Nucleus accumbens
core: Genotype F(1, 52) = 191.51, p < 0.001; Drd2
+/+ vs.
Drd2+/− p < 0.001. Nucleus accumbens shell: Genotype
F(1, 52) = 170.40, p < 0.001; Drd2
+/+ vs. Drd2+/− p < 0.001.
Olfactory tubercle: Genotype F(1, 52) = 109.67, p < 0.001;
Drd2+/+ vs. Drd2+/− p < 0.001. Dtail: Genotype F(1, 52) =
200.53, p < 0.001; Drd2+/+ vs. Drd2+/− p < 0.001. Dtail:
Genotype F(1, 52) = 192.29, p < 0.001; Drd2
+/+ vs. Drd2+/−
p < 0.001).
D1 Receptor Binding
The levels and distribution of D1 dopamine receptors in
the basal forebrain, associated with Drd2 expression, with
exposure to CMS, and with ETOH intake, were studied
with in vitro [3H]SCH23390 autoradiography (Figure 3). D1
dopamine receptor levels were lower in Drd2+/− and Drd2−/−
mice, compared with Drd2+/+, in all regions examined (Three-
way ANOVA, DL striatum: Genotype F(2, 69) = 15.24,
p < 0.001; Drd2+/+ vs. Drd2+/−p < 0.001, Drd2+/+ vs.
Drd2−/−p < 0.001). VL striatum: Genotype F(2, 69) = 13.36,
p < 0.001; Drd2+/+ vs. Drd2+/−p < 0.001, Drd2+/+ vs.
Drd2−/−p < 0.001). DM striatum: Genotype F(2, 69) = 11.50,
p < 0.001; Drd2+/+ vs. Drd2+/−p < 0.001, Drd2+/+ vs.
Drd2−/−p = 0.002). VM striatum: Genotype F(2, 69) = 8.16,
p < 0.001; Drd2+/+ vs. Drd2+/−p = 0.001, Drd2+/+ vs.
Drd2−/−p = 0.015). Nucleus accumbens core: Genotype
F(2, 69) = 6.64, p = 0.001; Drd2
+/+ vs. Drd2+/−p = 0.002,
Drd2+/+ vs. Drd2−/−p = 0.035). Nucleus accumbens shell:
Genotype F(2, 69) = 5.344, p = 0.007; Drd2
+/+ vs. Drd2+/−p =
0.007, Drd2+/+ vs. Drd2−/−p = 0.039). Olfactory tubercle:
Genotype F(2, 69) = 5.325, p = 0.007; Drd2
+/+ vs. Drd2+/−p =
0.007, Drd2+/+ vs. Drd2−/−p = 0.031). Dtail: Genotype
F(2, 69) = 21.75, p < 0.001; Drd2
+/+ vs. Drd2+/−p = 0.007,
Drd2+/+ vs. Drd2−/−p < 0.001). Vtail: Genotype F(2, 69) =
13.96, p < 0.001; Drd2+/+ vs. Drd2+/−p < 0.001, Drd2+/+ vs.
Drd2−/−p = 0.017).
Correlations between Receptor Binding and
Ethanol Intake
ETOH intake in Drd2+/+ mice was negatively correlated with
[3H]raclopride specific binding in the VM striatum (r = –0.54,
p = 0.03) and the DL striatum (r = −0.5, p = 0.04) (Figure 4).
Ethanol intake in Drd2−/−mice was positively correlated with
[3H]WIN35428 specific binding in all regions studied (DL r =
0.73, p = 0.004; VL r = 0.76, p = 0.003; DM r = 0.657,
p = 0.014; VM r = 0.722, p = 0.005; NAC r = 0.791, p = 0.001;
OT r = 0.680, p = 0.011; Dtail r = 0.671, p = 0.012; Vtail
r = 0.698, p = 0.008) (Figure 5).
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FIGURE 2 | [3H]Raclopride specific binding in the basal forebrain of
Drd2+/+ and Drd2+/−mice. The bars represent mean + S.E.M.; C, control;
E, ethanol; S, chronic mild stress; SE, chronic mild stress and ethanol;
Drd2+/− measures are significantly different from the respective Drd2+/+
measures (for details please see Results).
Discussion
Overall, the current and our previous study (Delis et al., 2013)
show that lower ETOH intake in Drd2+/+ mice exposed to 4
weeks of CMS is associated with higher D2 receptor levels in
the striatum and that ETOH intake is negatively correlated with
D2 receptor levels. In Drd2+/− mice, D2 receptor levels are not
affected by any treatment; perhaps their low expression levels do
not allow for a modulatory role. In these mice, CMS exposure
leads to higher ETOH intake and to higher DAT levels in the
striatum and the n. accumbens. In Drd2−/− mice, DAT levels do
not change in response to the applied treatments, but they are
positively correlated with ETOH intake. In addition, we show a
significant decrease in D1 dopamine receptor levels throughout
the dopaminergic basal forebrain ofDrd2+/− andDrd2−/−mice,
which is not affected by the applied treatments. Our findings on
the regulation of ethanol consumption by CMS,Drd2 expression,
and markers of dopamine neurotransmission are schematically
presented in Figure 6.
Drd2 Knockout Decreases DAT and Dopamine D1
Receptor Levels
Drd2+/− and −/− mice have significantly lower DAT levels
in the dopaminergic basal forebrain, compared with Drd2+/+
mice. Previous studies have shown that the lack of dopamine
D2 receptors, which include the presynaptic D2 autoreceptors
FIGURE 3 | [3H]SCH23390 specific binding in the basal forebrain of
Drd2+/+, Drd2+/−, and Drd2−/−mice. The bars represent mean + S.E.M.;
C control, E ethanol, S chronic mild stress, SE chronic mild stress and ethanol;
Drd2+/− and Drd2−/− measures are significantly different from the respective
Drd2+/+ measures (for details please see Results).
and the post-synaptic D2 receptors, leads to increased stimulus-
induced DA release, increased extracellular DA half-life, lower
DA clearance, and lower DA uptake (Dickinson et al., 1999;
Rouge-Pont et al., 2002; Benoit-Marand et al., 2011). Our finding
of lower DAT levels in Drd2−/− mice suggests that the lack of
Drd2 expression leads to slower clearance and lower DA uptake
in vivo, not only because of disinhibited DA release, but also
because of a decrease in DAT levels which, in turn, could be a
direct result of the disrupted DAT - D2 autoreceptor interaction
(Lee et al., 2007).
Our finding of lower D1 receptor levels in Drd2+/− and
Drd2−/− mice, compared with Drd2+/+, is in agreement
with previous receptor binding and early gene expression
studies showing lower D1 receptor binding (Short et al., 2006)
and blunted D1-mediated c-fos expression in Drd2−/− mice
(Schmauss et al., 2002).
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FIGURE 4 | Significant correlations between D2 receptor levels
([3H]raclopride specific binding, nCi/mg tissue) and total ethanol
intake (g ETOH/kg b.w.) in Drd2+/+ and Drd2+/− mice in the
ventrolateral and ventromedial striatum.
Lower Dopamine D1 Receptor and DAT Levels
are Associated with Lower ETOH Preference
Studies show that ETOH intake/preference is negatively
associated with dopamine D2 receptor levels (Stefanini et al.,
1992; McBride et al., 1993; Volkow et al., 1996; Thanos et al.,
2001, 2004, 2005), which predicts that Drd2+/− and Drd2−/−
mice would have higher ethanol intake/preference, compared
withDrd2+/+. This, however, is not the case (Phillips et al., 1998;
Delis et al., 2013). The paradoxical finding of lower ETOH intake
and preference in Drd2+/− and Drd2−/− mice, compared with
Drd2+/+, has been explained by the lack of reward-mediating
D2 receptors. An additional plausible explanation is suggested
by the current study and involves the lower D1 receptor levels
in Drd2+/− and Drd2−/− C mice. D1 receptor antagonism
prevents the reward potentiating effects of alcohol in the
intracranial self-stimulation paradigm (Fish et al., 2014) and
decreases ETOH seeking as well as ETOH conditioned place
preference (Liu and Weiss, 2002; Hamlin et al., 2007; Chaudhri
et al., 2009; Bahi and Dreyer, 2012; Pina and Cunningham,
2014; Sciascia et al., 2014; Young et al., 2014), while D1 agonism
increases ETOH self-administration (D’souza et al., 2003) and
ethanol-induced motor sensitization (Abrahao et al., 2011).
Since the rewarding properties of ETOH are decreased by D1
receptor antagonism, we conclude that the lower D1 striatal
receptor levels in Drd2+/− and Drd2−/− C mice contribute
to their lower ETOH intake/preference, compared with
Drd2+/+ mice.
Our finding of lower DAT levels in the dopaminergic basal
forebrain of the non-preferring Drd2+/− and Drd2−/− C mice
is in agreement with the lower ETOH intake levels in DAT−/−
mice, compared with DAT+/+ (Savelieva et al., 2002; Mittleman
et al., 2011) (but see Hall et al., 2003) and complementary to
findings of higher dopamine uptake and higher DAT levels in
alcohol preferring HAD rats (Carroll et al., 2006) and ethanol
preferring monkeys (Mash et al., 1996). On the other hand,
studies show that ethanol preferring Sardinian rats have lower
DAT levels (Casu et al., 2002) and that DAT levels fluctuate
periodically as a function of the duration of ETOH exposure
(Hamdi and Prasad, 1991). Studies in humans suggest that
alcoholism, particularly Cloninger type I, is associated with lower
DAT levels in the dorsal rather than the ventral striatum (Dobashi
et al., 1997; Repo et al., 1999; Tupala et al., 2001), although other
studies are often inconclusive (Xu and Lin, 2011) or show DAT
associations with other aspects of alcohol addiction, such as visual
and somatosensory hallucinations (Limosin et al., 2004; Huber
et al., 2007), the severity of withdrawal (Schmidt et al., 1998;
Gorwood et al., 2003), and novelty seeking (Bau et al., 2001;
Laine et al., 2001) but not ETOH intake per se. It is obvious that
the role of DAT in the regulation of ETOH preference remains
inconclusive, particularly in humans. The findings of this study
are in line with a majority of preclinical studies and suggest that
in the Drd2 genetic model of ETOH intake, lower DAT levels
contribute to lower levels of ETOH intake.
ETOH Intake in CMS-exposed Normal Mice is
Moderated by D2 Receptors
In this study we show that among ETOH consuming Drd2+/+
mice, those exposed to CMS have significantly higher D2
receptor levels in regions of the motor (lateral) and cognitive
(dorsomedial) striatum. CMS-exposed Drd2+/+ mice have lower
ETOH intake compared to non-CMS exposed Drd2+/+ mice
(Delis et al., 2013), which suggests that high D2 receptor levels
moderate ETOH intake, in agreement with previous studies in
rodents and humans. Ethanol preferring rats express low D2
receptor levels (Stefanini et al., 1992; McBride et al., 1993; Thanos
et al., 2001) in agreement with studies in humans showing that
alcoholism is associated with lower post mortem and in vivo
D2 receptors (Blum et al., 1990; Volkow et al., 1996; Tupala
et al., 2001). In addition, Drd2 overexpression decreases ETOH
intake and preference in ETOH preferring and non-preferring
rodents (Thanos et al., 2001, 2004, 2005), which is in agreement
with studies in humans showing higher D2 receptor levels in
unaffected members of families with alcoholics (Volkow et al.,
2006). Our finding of a negative correlation between ETOH
intake and D2 receptor levels in all ETOH consuming Drd2+/+
mice is in agreement with the aforementioned studies and
supports the protective role of D2 receptors against ETOH
overconsumption.
The lower ETOH intake levels in stressed Drd2+/+ mice
were, perhaps, the most intriguing finding of our previous study
(Delis et al., 2013). Instead of increasing ETOH intake after CMS
exposure, as would be suggested if ethanol consumption was a
self-medication strategy to counteract stress, the mice decreased
consumption. Similar findings of lower ethanol consumption
when stress and ethanol are experienced together or in proximity
have been previously presented (Rockman and Glavin, 1986; van
Erp and Miczek, 2001; van Erp et al., 2001; Chester et al., 2004;
Clark et al., 2007; Deehan et al., 2011; Norman et al., 2014). A
likely explanation of our result is that the stressors, in spite of
being chronic and incontrollable, were presented to the mice in
the same order each week, which may have allowed them to cope
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FIGURE 5 | Significant correlations between DAT levels
([3H]WIN35428 specific binding, nCi/mg tissue) and total ethanol
intake (g ETOH/kg b.w.) in Drd2+/+, Drd2+/−, and Drd2−/− mice in
representative motor (dorsolateral striatum), cognitive (dorsomedial
striatum), and limbic (nucleus accumbens) regions of the
dopaminergic basal forebrain.
with stress (Miller, 1981; Koolhaas et al., 2011; Herman, 2013;
Lucas et al., 2014). This would also explain the lack of effect
of CMS on D2 receptors in Drd2+/+ mice, in agreement with
studies showing normal D2 receptor levels in CMS-resilient rats
(Zurawek et al., 2013). In agreement with this hypothesis, DRD2
antagonism or knockout impair cognitive function (Glickstein
et al., 2002; Tillerson et al., 2006;Watson et al., 2012), which could
account for the presumed difficulty of theDrd2+/− andDrd2−/−
mice to predict the CMS stressors.
DAT Levels Increase after CMS and Remain High
in ETOH-consuming CMS-exposed Drd2+/− Mice
In this study we observe a significant increase in DAT levels
in CMS-exposed Drd2+/− mice (S and SE), in most regions
of the dopaminergic basal forebrain studied, compared with
Drd2+/− animals that were not exposed to CMS (C and E). Our
finding is in agreement with previous preclinical studies showing
higher DAT levels and function after exposure to various types of
stress. DAT levels/function increase after chronic restraint stress
(Copeland et al., 2005), immobilization stress (Lucas et al., 2007),
social defeat (Novick et al., 2011), variable stress (Kohut et al.,
2012), prenatal stress (Converse et al., 2013), and isolation rearing
(Yorgason et al., 2013). In humans, the DAT gene contains a
40 nucleotide repeat polymorphism in the 3′ non-coding region
that modulates the expression of the gene. This polymorphism
may present with a variable number of repeats (R), with the
9R and 10R being the most frequent. The 9R polymorphism is
particularly interesting in humans since its presence is associated
with increased DAT expression levels (Michelhaugh et al., 2001;
van de Giessen et al., 2009; Faraone et al., 2014) as well as post-
traumatic stress disorder (Fuke et al., 2001; Segman et al., 2002;
Valente et al., 2011; Hoexter et al., 2012). Therefore, preclinical
and clinical findings converge to the suggestion that exposure
to stress, including chronic mild stress, leads to increased DAT
levels in the dopaminergic basal forebrain, in agreement with
our findings of higher DAT levels in Drd2+/− mice exposed to
CMS. In addition, in humans, the high DAT expression levels
induced by the 9R polymorphism are associated with novelty
seeking in alcoholics (Bau et al., 2001; Laine et al., 2001) and with
severe alcohol withdrawal symptomatology (Schmidt et al., 1998;
Gorwood et al., 2003). In animals, high DAT levels are associated
with chronic ethanol consumption in HAD rats (Carroll et al.,
2006) and are markers of high ethanol preference in primates
(Mash et al., 1996). Based on the above, we postulate that CMS-
induced increases in DAT levels contribute to the higher ETOH
intake observed in Drd2+/− SE mice. Finally, although DAT
levels do not change significantly between treatment groups in
Drd2−/− mice, they are positively correlated with ETOH intake,
which is in the same line with our findings in Drd2+/− mice
and suggests that in the absence of Drd2 expression, ETOH
intake is primarily and positively regulated by DAT expression
levels.
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FIGURE 6 | Ethanol intake regulation by Drd2 expression, dopamine receptor and transporter changes, and exposure to chronic mild stress.
Conclusions
The present study shows that in normal mice, ETOH intake is
primarily, and negatively, regulated by dopamine D2 receptors.
ETOH overconsumption under CMS is prevented in normal
mice expressing high dopamine D2 receptor levels. The study
also suggests that in mice with limited Drd2 expression, ETOH
overconsumption is prevented by lower D1 receptor and DAT
levels. In these mice, ETOH intake under CMS is positively
regulated by DAT. The existence of a regulatory role of
DAT on ETOH intake is also evident in mice with no Drd2
expression, in which DAT levels are positively correlated with
ETOH intake. These findings illustrate the significant interaction
between an environmental factor -stress- and Drd2 and Dat,
two fundamental genetic factors in the regulation of reward
perception and handling (Comings and Blum, 2000; Blum
et al., 2011, 2014). Our study is in agreement with previous
findings on the role of D2 receptors in ETOH intake and
reveals new mechanisms of ETOH intake regulation by D1 and
DAT. Studies of neurotransmitter systems that interact with the
dopaminergic system and that are involved in ETOH reward and
addiction, such as the GABAergic and endocannabinoid systems,
are necessary in order to further comprehend the biological
mechanisms underlying the complex interactions between stress,
brain, and ETOH consumption.
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